| Closed |
S0429 |
Docetaxel and Cetuximab Chemoradiation in Stage III NSCLC |
4/1/2006 |
8/15/2009 |
40% |
|
Published
|
| Closed |
S1600 |
Effect of Immune-Enhancing Nutrition on Radical Cystectomy Outcomes |
2/21/2019 |
10/20/2023 |
100% |
|
|
| Closed |
SWOG-8530 |
Efficacy of Prednisone in Refractory and Relapsing Multiple Myeloma and Measurement of Glucocorticoid Receptors |
|
1/1/1990 |
100% |
|
Published
|
| Closed |
S1013 |
EGFR Skin Toxicity Validation |
11/15/2011 |
10/1/2016 |
94% |
|
|
| Closed |
S0114 |
EGFRvIII Peptide Vaccine |
11/1/2002 |
6/1/2006 |
47% |
|
|
| Closed |
S9918 |
Elderly AML |
2/1/2000 |
3/15/2001 |
29% |
|
|
| Closed |
S0112 |
Elderly AML |
8/1/2001 |
4/1/2003 |
100% |
|
Published
|
| Closed |
S9720 |
ENDOMETRIAL |
2/15/1998 |
7/15/2000 |
100% |
|
Published
|
| Closed |
S9632 |
Enhancing Well-Being During Breast Cancer Recurrence |
6/1/1997 |
8/1/1998 |
100% |
|
Published
|
| Closed |
SWOG-9314 |
ER and PgR Predicting Response to Tamoxifen |
9/1/1993 |
12/15/1995 |
91% |
|
Published
|
| Closed |
S0101 |
ESOPHAGEAL |
4/15/2001 |
2/1/2003 |
100% |
|
Published
|
| Closed |
S0356 |
ESOPHAGEAL |
9/15/2004 |
8/1/2008 |
100% |
|
Published
|
| Closed |
S0415 |
ESOPHAGEAL |
10/15/2004 |
1/1/2007 |
100% |
|
Published
|
| Closed |
S0414 |
ESOPHAGEAL |
5/1/2005 |
9/1/2007 |
29% |
|
Published
|
| Closed |
SWOG-9046 |
Evaluation of 10-EdAM in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck, Phase II |
12/15/1990 |
4/1/1992 |
100% |
|
Published
|
| Closed |
SWOG-8220 |
Evaluation of 2' Deoxycorformycin (DCF) in Advanced Mycosis Fungoides |
8/11/1982 |
3/22/1985 |
|
|
|
| Closed |
SWOG-8303 |
Evaluation of 2'Deoxycoformycin in Refractory Multiple Myeloma TEMPORARILY CLOSED: 8/17/84 |
4/25/1983 |
3/22/1985 |
|
|
Published
|
| Closed |
SWOG-9122 |
Evaluation of 5-Fluorouracil By Intermittent Infusion in Combination with Alpha-Interferon for Patients with Advanced Renal Cell Carcinoma, Phase II |
6/1/1992 |
10/15/1993 |
100% |
|
Published
|
| Closed |
SWOG-7940 |
Evaluation of 5-FU vs. A Phase II Drug in Metastatic Adeno- carcinoma of the Large Bowel |
2/27/1980 |
5/5/1982 |
|
|
|
| Closed |
SWOG-8604 |
Evaluation of 6-Thioguanine (6-TG)(NSC-752) in Refractory and Relapsing Myeloma |
10/15/1986 |
12/1/1987 |
|
|
Published
|
